Platelets are anucleated blood elements highly potent at generating extracellular vesicles (EVs) called microparticles (MPs). Whereas EVs are accepted as an important means of intercellular communication, the mechanisms underlying platelet MP internalization in recipient cells are poorly understood. Our lipidomic analyses identified 12(S)-hydroxyeicosatetranoic acid [12(S)-HETE] as the predominant eicosanoid generated by MPs. Mechanistically, 12(S)-HETE is produced through the concerted activity of secreted phospholipase A 2 IIA (sPLA 2 -IIA), present in inflammatory fluids, and platelet-type 12-lipoxygenase (12-LO), expressed by platelet MPs. Platelet MPs convey an elaborate set of transcription factors and nucleic acids, and contain mitochondria. We observed that MPs and their cargo are internalized by activated neutrophils in the endomembrane system via 12(S)-HETE. Platelet MPs are found inside neutrophils isolated from the joints of arthritic patients, and are found in neutrophils only in the presence of sPLA 2 -IIA and 12-LO in an in vivo model of autoimmune inflammatory arthritis. Using a combination of genetically modified mice, we show that the coordinated action of sPLA 2 -IIA and 12-LO promotes inflammatory arthritis. These findings identify 12(S)-HETE as a trigger of platelet MP internalization by neutrophils, a mechanism highly relevant to inflammatory processes. Because sPLA 2 -IIA is induced during inflammation, and 12-LO expression is restricted mainly to platelets, these observations demonstrate that platelet MPs promote their internalization in recipient cells through highly regulated mechanisms.
Platelets are anucleated blood elements highly potent at generating extracellular vesicles (EVs) called microparticles (MPs). Whereas EVs are accepted as an important means of intercellular communication, the mechanisms underlying platelet MP internalization in recipient cells are poorly understood. Our lipidomic analyses identified 12(S)-hydroxyeicosatetranoic acid [12(S)-HETE] as the predominant eicosanoid generated by MPs. Mechanistically, 12(S)-HETE is produced through the concerted activity of secreted phospholipase A 2 IIA (sPLA 2 -IIA), present in inflammatory fluids, and platelet-type 12-lipoxygenase (12-LO), expressed by platelet MPs. Platelet MPs convey an elaborate set of transcription factors and nucleic acids, and contain mitochondria. We observed that MPs and their cargo are internalized by activated neutrophils in the endomembrane system via 12(S)-HETE. Platelet MPs are found inside neutrophils isolated from the joints of arthritic patients, and are found in neutrophils only in the presence of sPLA 2 -IIA and 12-LO in an in vivo model of autoimmune inflammatory arthritis. Using a combination of genetically modified mice, we show that the coordinated action of sPLA 2 -IIA and 12-LO promotes inflammatory arthritis. These findings identify 12(S)-HETE as a trigger of platelet MP internalization by neutrophils, a mechanism highly relevant to inflammatory processes. Because sPLA 2 -IIA is induced during inflammation, and 12-LO expression is restricted mainly to platelets, these observations demonstrate that platelet MPs promote their internalization in recipient cells through highly regulated mechanisms.
platelets | microparticles | neutrophils | 12-lipoxygenase | phospholipase A 2 S mall extracellular vesicles (EVs) are implicated in physio (patho)logical contexts, such as immunity, reproduction, and cancer (1) (2) (3) (4) . They also include apoptotic bodies, the vesicles produced by apoptotic cells. Exosomes are EVs generated by exocytosis of multivesicular bodies ranging in size between 50 nm and 150 nm, whereas microparticles (MPs), also known as microvesicles, are vesicles of ∼100-1,000 nm diameter shed from the plasma membrane by cellular budding and fission (2) . EVs bear cellular components originating from the donor cells, and accumulating evidence suggests that they might transfer their material to recipient cells. The regulatory events implicated in the transfer of the EV cargo remain mostly undefined, however.
Platelets circulate in blood and patrol the vasculature to promote hemostasis. Although any cell lineage might shed MPs, platelets are particularly proficient at this function. Consistent with this, the blood is rich in MPs expressing platelet (and megakaryocyte) surface markers, and levels of platelet MPs increase in diseases in which platelets are activated (5) . Albeit anucleated, platelets represent a major blood reservoir of such components as nuclear factors (6, 7) , messenger RNA (mRNA) (8, 9) , microRNA (miRNA) (10) , and mitochondria (11) , which may be packaged inside MPs and transferred to nucleated recipients. A key event in the occurrence of such transfer is the binding of platelet MPs to cells. This may implicate selectins (12) and the recognition of phosphatidylserine, a phospholipid frequently exposed on MPs (13) , by lactadherin (14) and developmental endothelial locus-1 (15) . Indeed, miRNA-containing platelet MPs are internalized by endothelial cells, thereby altering the stability of mRNA in the recipient (16) . Platelets are also active participants in immunity (17) (18) (19) (20) ; platelet MPs are found in inflammatory conditions (1, 17, 21) and are ideally positioned to interact with immune cells.
Neutrophils patrol the vasculature and tissues at the ready to respond to an infectious agent or tissue insult (22) . Although neutrophils are considered terminally differentiated granulocytes, they can undergo important phenotypical and functional changes Significance On activation, blood platelets package components from their cytoplasm into microparticles (MPs), tiny vesicles released by cytoplasmic membrane budding and shedding. Given that MPs can impact other cellular lineages on internalization, we aimed to decipher the mechanisms promoting MP internalization by cellular recipients. We modeled MP internalization by neutrophils and identified a predominant lipid, 12(S)-hydroxyeicosatetranoic acid, as a mediator critical for the promotion of MP internalization. MPs were found inside neutrophils from individuals with rheumatoid arthritis, and their presence in neutrophils in the joints of mice treated with arthritogenic serum is dependent on the expression of enzymes implicated in the generation of 12(S)-hydroxyeicosatetranoic acid. These findings reveal a unique molecular mechanism implicated in MP internalization relevant to inflammatory processes.
once present in inflammatory exudates (23) . For instance, in rheumatoid arthritis (RA), the most common form of autoimmune joint inflammation, neutrophils are represented preponderantly in the diseased joint fluid and display a prolonged lifespan and reduced migratory activity, suggesting the accumulation of factor(s) in RA that promote neutrophil plasticity (23) (24) (25) .
Using autoimmune arthritis as a model of inflammation in which both MPs and neutrophils contribute (21, 26) , we reveal that MP cargo transfer from anucleated platelets to nucleated recipient neutrophils is dependent on the concerted activities of sPLA 2 -IIA present in the extracellular milieu and of 12-lipoxygenase (12-LO) present in platelet MPs. Our observations demonstrate that platelet MPs are not passively internalized by neutrophils, but rather that MPs promote their own internalization via a lipid mediator of inflammation. Considering that platelets (i) represent a substantial source of nuclear factors, noncoding RNAs, and functional organelles; (ii) are highly efficient at producing MPs; and (iii) are unique with respect to 12(S)-HETE expression, platelets might be specialized at transferring their material to other cells to modify them.
Results

MP Internalization by Neutrophils.
Assuming that the transfer of materials from platelets to neutrophils is biologically significant, we hypothesized that it necessarily would occur via finely controlled mechanisms. To identify key mediators involved in internalization, we further surmised that these mediators would be concomitantly expressed with platelet MPs. The secreted phospholipase A 2 (sPLA 2 ) enzymes hydrolyze membrane phospholipids in the sn-2 position, generating free fatty acids and lysophospholipids (27) . Although 10 different groups of sPLA 2 enzymes have been identified in humans, sPLA 2 group IIA (sPLA 2 -IIA) is (nonexclusively) expressed by platelets and is induced in inflammation (27, 28) . In RA, sPLA 2 -IIA is overexpressed in joint lubricating synovial fluid (SF) and amplifies the disease (28) . Whereas sPLA 2 -IIA has limited activity on the cellular plasma membrane (27) , it uses MPs as a substrate (27, 29, 30) . Like sPLA 2 -IIA, MPs accumulate in SF during RA, where they are frequently associated with neutrophils (11, 21, 28, 31, 32) .
In a preliminary set of experiments, we generated platelet MPs to verify whether they are internalized by neutrophils and whether sPLA 2 -IIA impacts this process. We used collagen to activate human platelets that had been labeled with 5-chloromethylfluorescein diacetate (CMFDA), a probe that passes freely through the platelet cell membrane and is converted to a fluorescent cell-impermeable product by cytosolic esterases (33) . Under these conditions, the fluorescent probe was encapsulated within platelets, and 96.8 ± 0.25% of the MPs shed from these platelets fluoresced (SI Appendix, Fig. S1A ). MPs isolated by centrifugation contained ∼0.1% remnant platelets and were of heterogeneous size (115 nm-538 nm; average, 346.3 ± 23.4 nm) (SI Appendix, SI Materials and Methods and Fig. S1 B, C, D, and F), consistent with the reported dimensions of platelet MPs (13) .
We then verified different categories of markers expected in EVs in MP preparations. Whereas mitochondria are typically absent in exosomes, they can be packaged inside MPs (11, 34) . Furthermore, the presence of a protein associated with the endosomal sorting complex required for transport (ESCRT), tumor susceptibility gene 101 protein (TSG101), is recognized in exosomes but underrepresented in MPs (34) . Thus, the platelet EV preparations used in this study were enriched in MPs, because a subset contained mitochondrial markers, whereas ESCRT proteins were undetectable (SI Appendix, Fig. S1 E and G) .
To determine the contribution of inflammatory stimuli and sPLA 2 -IIA to MP internalization by neutrophils, we treated the latter with autoimmune-relevant inflammatory stimuli [TNF/ GM-CSF and immune complexes, an agonist of the receptors for the Fc portion of IgG (FcγR)] in the presence or absence of sPLA 2 -IIA. We observed that MPs rapidly bound neutrophils independently of sPLA 2 -IIA and of any costimulation (SI Appendix, Fig. S2 A-E). In contrast, the combination of stimuli (TNF/GM-CSF and immune complexes) and sPLA 2 -IIA was necessary for efficient internalization of MPs ( Fig. 1 and SI Appendix, Fig. S3A ), which were identified in the neutrophil's cytoplasm in the vicinity of the endoplasmic reticulum, Golgi apparatus, and lysosome, but never by the recipient mitochondria (SI Appendix, Fig. S4 A-D) . Accordingly, an average of 20 ± 4 and 38 ± 3 MPs were internalized in neutrophils in the presence of sPLA 2 -IIA within 30 and 60 min, respectively. The internalization process occurred through dynamin-, clathrin-, and caveolin-dependent endocytosis (SI Appendix, Fig. S5 ), and was not unique to collagen-induced MPs. MPs generated by activating platelets with thrombin, a serine protease, and collagenrelated peptide, a specific glycoprotein VI agonist, also were internalized by neutrophils, and this was dependent on the presence of sPLA 2 -IIA (SI Appendix, Fig. S3B ). These results provide an ideal model for identifying the molecular process implicated in MP internalization following adhesion.
Although the sPLA 2 -IIA enzyme generates potent lipid mediators, it also acts as a receptor ligand (27, (35) (36) (37) . Thus, sPLA 2 -IIA might promote internalization either through the production of lipid mediators or through receptor binding and signaling. To assess the contribution of sPLA 2 -IIA catalytic activity to MP internalization, we made use of an inactive enzyme mutant, H48Q-sPLA 2 -IIA (27) . An important observation is that sPLA 2 -IIA catalytic activity was critical for the promotion of MP internalization ( Fig. 1) , ruling out the role of sPLA 2 -IIA receptor binding and pointing to the role of lipid mediator(s) in this process.
Platelet Microparticle Lipidomics. We next sought to identify the lipid trigger implicated in MP internalization. sPLA 2 -IIA generates lysophospholipids from MPs (27, 29) ; however, the complete set of lipid mediators expressed by MPs is unknown. Using tandem mass spectrometry to survey MP-derived lipid mediators, we confirmed that MPs are used as substrates by sPLA 2 -IIA, generating diverse lysophospholipids and fatty acids, including Representative confocal microscopy analyses of neutrophil cytoplasm (red) and nuclei (cyan) on incubation with MPs (green) for 2 h at 37°C in the absence or presence of recombinant human sPLA 2 -IIA or its catalytically inactive mutant H48Q-sPLA 2 -IIA. Neutrophils were left native (without stimulation), primed (TNF/ GM-CSF), or activated (TNF/GM-CSF and immune complexes) before MP incubation. MPs are seen at the surface (white arrows) and internalized (arrowheads). (Scale bars: 10 μm.) (Right) Graph bars indicating the relative localization (surface vs. intracellular) of the MPs, depending on the neutrophil and MP treatments. Data were obtained from 100 neutrophils per condition repeated at least three times with cells from different donors (n > 3). ***P < 0.0001 compared with MP condition, Mann-Whitney test.
arachidonic acid (AA; 20:4) (Fig. 2 A-D and SI Appendix, Fig. S6  A and B) . AA can be metabolized into eicosanoids, highly versatile mediators of multiple physiological and pathological processes ( Fig. 2E) (38, 39) . Indeed, examination of platelet MPs revealed, as in platelets (40) , the presence of enzymes [i.e., cyclooxygenase 1 (Cox-1), thromboxane synthase (TXs), and 12-LO] that metabolize AA into the eicosanoids thromboxane A 2 (TXA 2 ) and 12(S)-HETE (Fig. 2F) . These pathways are active in MPs as exogenous AA was metabolized into thromboxane B 2 (TXB 2 ; a stable metabolite of TXA 2 ) and 12(S)-HETE (Fig. 2G) . Consistent with this was the identification of TXB 2 Fig. S6C ).
Consequently, we added exogenous lipids to activated neutrophils and examined their role in internalization. We observed that, similar to sPLA 2 -IIA, 12(S)-HETE was sufficient to promote internalization by inducing neutrophils to internalize MPs ( Fig. 3 A and B and Movies S1 and S2). Conversely, lysophosphatidylcholine (SI Appendix, Fig. S7A ), carbocyclic TXA 2 (TXA 2c ; a stable analog of TXA 2 ), TXB 2 , and 12-hydroxyheptadecatrienoic acid (12-HHTrE) produced concurrently with TXA 2 by TXs (41) had no impact on MP internalization (Fig. 3B) . Moreover, a COX inhibitor demonstrated no effect on MP internalization, confirming that the COX products are dispensable (SI Appendix, Fig. S7B) .
Next, to confirm that 12(S)-HETE is the lipid trigger implicated in sPLA 2 -IIA-induced MP internalization, we produced fluorescent MPs from platelets isolated from platelet-type 12-LOdeficient (ALOX12 −/− ) mice and from their wild type (WT) control littermates (ALOX12 +/+ ). Remarkably, ALOX12 −/− MPs, which cannot metabolize AA into 12(S)-HETE (Fig. 3C) , were not internalized by neutrophils, even in the presence of sPLA 2 -IIA (Fig. 3D) , demonstrating the critical involvement of platelet MP 12-LO in this process. Neutrophils express the 12(S)-HETE high-affinity receptor BLT 2 and the leukotriene B 4 (LTB 4 ) highaffinity receptor BLT 1 . Using an antagonist of BLT 2 (LY255283), along with an antagonist of BLT 1 (CP105696) for comparison, we confirmed the involvement of 12(S)-HETE and its receptor BLT 2 in the internalization process (Fig. 3E) . The contribution of BLT 1 was significant, but less prominent, in agreement with the lower affinity of 12(S)-HETE for this receptor, or suggestive of a modest role for LTB 4 in this process (42) .
Platelet-type 12-LO expressed by human platelets generates the S enantiomer of 12-hydroxyeicosatetraenoic acid (12-HETE), designated 12(S)-HETE, whereas the R enantiomer, 12(R)-HETE, is produced by the 12-LO expressed by leukocytes and skin fibroblasts, or through the noncatalytic derivation of AA by cytochrome P450 (43) . To verify whether this mechanism of internalization might apply to other cell lineage MPs (deficient in platelet-type 12-LO), we compared the relative impacts of 12(S)-HETE and 12(R)-HETE on internalization. We found that 12(S)-HETE, but not 12(R)-HETE, is specifically involved in MP internalization (Fig.  3F) . ALOX12
−/− MPs were not internalized even in the presence of exogenous 12(S)-HETE, providing further support for the contribution of platelet-type 12-LO in this process (Fig. 3D ). In addition, using red fluorescent ALOX12 −/− platelets and green fluorescent ALOX12
+/+ platelets to generate red ALOX12
−/−
MPs and green ALOX12 +/+ MPs, respectively, we found that 12(S)-HETE produced from MPs is incapable of promoting internalization of neighboring MPs lacking 12-LO (Fig. 3D ), suggesting that the internalization process revealed here might be unique to 12(S)-HETE-expressing MPs (i.e., platelet MPs).
MP Internalization in Disease. Neutrophils, platelet MPs (11, 21, 31, 32), sPLA 2 -IIA (28), and inflammatory stimuli all coexist in RA SF. We used SF from patients with RA that contained an abundance of platelet MPs (Fig. 4A ) to determine whether platelet MPs can be found within neutrophils. Using anti-CD41 and anti-CD66b monoclonal antibodies to label platelet MPs and neutrophils, respectively, we could discern significant platelet MP signals both at the surface and inside neutrophils (mostly near or at the nucleus) in RA SF (Fig. 4 B and C). We observed a similar pattern of CD41 + MP expression inside peripheral neutrophils that had been incubated with platelet MPs, but only in the presence of sPLA 2 -IIA (Fig. 4B) .
We next used the K/BxN serum transfer model of arthritis, a disease model in which both sPLA 2 -IIA and platelet MPs are implicated (21, 28) , to validate the MP internalization process in inflammation. Because C57Bl6/J mice naturally lack sPLA 2 -IIA (28), we used transgenic mice expressing human sPLA 2 -IIA (sPLA 2 -IIA TGN , in a C57Bl6/J background) (44) and included WT C57Bl6/J mice as controls. We observed that on injection into the tail vein, fluorescent ALOX12 +/+ MPs quickly localized inside neutrophils in the arthritic ankles of sPLA 2 -IIA-expressing mice (Fig. 4 D and E ). An important observation is the absence of MP localization inside neutrophils in mice lacking sPLA 2 -IIA, confirming the essential role of sPLA 2 -IIA in the internalization process in vivo. The internalization was through MP-derived 12(S)-HETE; ALOX12 −/− MPs failed to localize in neutrophils, even in mice expressing sPLA 2 -IIA ( Fig. 4 D and E) . Thus, the concerted actions of sPLA 2 -IIA-and MP-derived 12-LO trigger MP internalization during inflammation.
Transfer of an Elaborate Microparticle Cargo Inside Neutrophils.
Having confirmed efficient internalization of fluorescently labeled platelet MPs, we proceeded to verify the actual transfer of three distinct platelet components (i.e., a cytosolic protein, a nucleic acid, and an organelle) to neutrophils. Because megakaryocytes perform several rounds of endomitosis before platelet production, the platelet content can be particularly enriched in cellular components. Although lacking a nucleus (and thus transcription), the transcription factors NF-κB (7) and peroxisome proliferator-activated receptor (PPAR) have been reported in the platelet cytosol (6) . The complete set of transcription factors expressed by platelets is unknown, however, and whether they are encapsulated in MPs has not been investigated. We determined that 80 different transcription factors, belonging to seven distinct structural families (45) (SI Appendix, Dataset S1) are found in platelets (SI Appendix, Fig. S8A ) and are packaged in MPs (SI Appendix, Fig. S8B ), including NF-κB and chicken ovalbumin upstream promoter-transcription factor (COUP-TFI) (Fig. 5A) . The latter, which is involved in neural maturation (46) , was highly expressed in platelet MPs and was undetectable by immunofluorescence in neutrophils ( Fig. 5B and SI Appendix, Dataset S1). We used this information to monitor the transfer of transcription factors to the recipient. We observed that through sPLA 2 -IIA activity, COUP-TFI was efficiently transferred to neutrophils, where it remained in the cytosol (Fig. 5B) . Furthermore, the COUP-TFI protein detected in the platelet MPs retained its DNA-binding activity, as revealed by DNA-protein interaction assays (SI Appendix, Fig. S8C ), thereby indicating that it might impact recipient cell transcription on translocation to the nucleus. Platelets contain mRNAs (8, 47) and noncoding RNAs (ncRNAs) (10), encapsulated inside MPs on budding and shedding (16) . We have established the repertoire of nucleic acids from platelet MPs, showing that MPs express a variety of mRNAs coding for proteins implicated in multiple biological processes (SI Appendix, Fig. S8D and Dataset S2). Of interest, ncRNAs, such as transfer RNAs, ribosomal RNAs, and miRNAs, also were identified in MPs. We performed a more precise assessment of MP miRNAs using miRNA arrays, which identified the presence of immature and mature miRNAs (SI Appendix, Dataset S3). An miRNA produced independently of Dicer activity, miR-451 (48), has been implicated in immunity and inflammation (49) and appeared to be one of the most abundantly expressed miRNAs in MPs ( S9 ) and transfer of miR-451 to these recipient cells (Fig. 5D) . Furthermore, we found that MP-derived miR-451 cleaved its cytoplasmic target sequence, establishing that platelet MPs can transfer functional nucleic acids to recipient cells through sPLA 2 -IIA (Fig. 5D) .
Platelets contain an average of four mitochondria, which can be packaged inside MPs, thereby forming mitochondriacontaining MPs (11) . Because only a subset of MPs contains mitochondria (11), we used confocal microscopic analyses and a combination of cytosolic and mitochondrial fluorescent dyes to distinguish mitochondria-deficient MPs and mitochondria-containing MPs. We found that the internalization of mitochondria-containing MPs by neutrophils depends on the presence of sPLA 2 -IIA (Fig.  5E ). The efficient transfer of mitochondria through MPs was further validated by electron microscopy (Fig. 5F) . Thus, the activity of sPLA 2 -IIA on MPs mediates the transfer of a broad repertoire of platelet components to neutrophils, including cytosolic proteins (e.g., transcription factors), nucleic acids (e.g., miRNA) and organelles (e.g., mitochondria).
Concerted Action of sPLA 2 -IIA and 12-LO in Vivo. The internalization of MPs by activated neutrophils requires 12(S)-HETE; however, whether this process is proinflammatory or anti-inflammatory is unknown. Under the hypothesis that the internalization of MPs by neutrophils might be biologically relevant, we verified the impact of the concerted activities of sPLA 2 -IIA and 12-LO in vivo. To this end, we crossed ALOX12 −/− mice with sPLA 2 -IIA TGN mice, which reportedly exhibit skin abnormalities reminiscent of psoriasis but with no neutrophil infiltration (44) , to generate sPLA 2 -IIA TGN ALOX12 −/− mice. We observed that ablation of the ALOX12 gene in sPLA 2 -IIA TGN mice had no effect on the skin phenotype, although 12-LO expression was eliminated in blood platelets ( Fig. 6 A and B) . Furthermore, we also confirmed that neutrophilia, which has been reported in sPLA 2 -IIA TGN mice (50), occurred independently of 12-LO, and that the other blood cell lineages were unaffected in the transgenic mice ( Fig. 6C and SI  Appendix, Fig. S10 ). Taken together, these data suggest that the ) were injected i.v. into the mouse tail vein, and the neutrophils retrieved in the arthritic joints were collected for confocal microscopy analyses. (D) Representative confocal microscopy images of neutrophils identified using FITC-conjugated anti-GR1 and the presence of neutrophil distinctive polymorphonuclei (cyan). The presence of MPs was determined as red fluorescence. (E) MFI of the red fluorescence signals present intracellularly was measured on 100 neutrophils per mice. Bar graph presents specific MFI (i.e., MFI of MP injected mice minus PBS-injected mice) (n = 6) **P < 0.005; ***P < 0.0001, Mann-Whitney test.
concerted actions of sPLA 2 -IIA and 12-LO do not support neutrophil-independent psoriasis-like disease or neutropoiesis.
We next used the K/BxN model of inflammatory arthritis to examine the roles of sPLA 2 -IIA and 12-LO in a relevant pathology in which both neutrophils and platelet MPs participate. In agreement with a previous study (28) , we confirmed more marked development of arthritis in sPLA 2 -IIA TGN mice compared with sPLA 2 -IIA-deficient mice (Fig. 6D) . Moreover, the sPLA 2 -IIA   TGN   ALOX12 −/− mice developed only modest arthritis, similar to sPLA 2 -IIA-deficient mice. Given that ablation of the ALOX12 gene in C57BL6 mice (deficient in sPLA 2 -IIA) had no impact on arthritis, these data establish that sPLA 2 -IIA and 12-LO work in concert to promote inflammation in vivo. Furthermore, i.v. injection of fluorescent ALOX12 +/+ platelet MPs into these groups of mice showed preferential localization in neutrophils in the joints of sPLA 2 −/− mice was more efficient than that for ALOX12 −/− MPs, suggesting that the former provide sufficient 12(S)-HETE for their internalization (Fig. 6F) .
Discussion
The rich collection of components with apparently no or only modest roles in anucleated platelets, and the platelet's proficiency to produce MPs under a variety of inflammatory conditions was the impetus for our study. Our results identify sPLA 2 -IIA as an enzyme working in concert with platelet MP 12-LO to promote internalization ( Fig. 7 and SI Appendix, Fig. S8G ). The fact that two enzymes are required for MP internalization demonstrates that the internalization process is tightly regulated, in agreement with the potential significance of this process. Because sPLA 2 -IIA is an extracellular enzyme induced only in inflammatory exudates, this ensures that MPs are not internalized in neutrophils, unless the neutrophils reach the inflammatory site. Furthermore, the fact that neutrophils require activation also points to an additional (17, 21, 27) . Whereas the AA liberated by MPs can be metabolized into eicosanoids by enzymes expressed by other cells in the vicinity (30) , our lipidomic approach shows that the action of sPLA 2 -IIA on MPs generates eicosanoids, a process requiring the activity of enzymes packaged inside MPs, consistent with our proteomic analyses and those reported by other investigators (51, 52) . Thus, with their membrane composition and content of functional enzymes, platelet MPs represent an extraordinary source of lipid mediators implicated in a vast range of physio(patho)logical functions when bathed in an environment rich in sPLA 2 -IIA. Although other sPLA 2 groups other than sPLA 2 -IIA might potentially use MPs as a substrate if present in sufficient quantities, our findings support the proposal that a physiological role for sPLA 2 -IIA is the promotion of platelet MP functional activities, such as internalization.
Whereas sPLA 2 -IIA can use platelet MPs to generate proinflammatory 12(S)-HETE, other eicosanoids, produced by platelets and other cell lineages, also make significant contributions to arthritis. It was previously shown using the K/BxN serum transfer model of autoimmune arthritis that platelet COX-1 could generate large quantities of extracellular prostaglandin H 2 , which itself was metabolized transcellularly by the prostaclycin synthase expressed by fibroblast-like synoviocytes (53) . The generation of prostacyclin by fibroblast-like synoviocytes amplifies inflammation, and, accordingly, the ablation of the gene coding for prostacyclin receptor reduces arthritis in vivo (54) . The eicosanoid LTB 4 is also an important lipid mediator implicated in arthritis, and mice deficient in 5-lipoxygenase (the enzyme regulating its biosynthesis) and in BLT 1 (the high-affinity receptor for LTB 4 ) are resistant to arthritogenic K/BxN serum (26, 55) . Herein we shed light on the role of platelet-type 12-LO in inflammatory arthritis. Consistent with this is the observation that arthritis is also attenuated in mice deficient in BLT 2 , a high-affinity receptor for 12(S)-HETE (and 12-HHTrE) (56) . Moreover, the contribution of platelet-type 12-LO could be determined only in mice expressing sPLA 2 -IIA, providing further support for the coupling between sPLA 2 -IIA and platelet-type 12-LO.
The internalization process revealed in this study occurs independently of COX-1, ruling out the involvement of other major lipid mediators produced by platelets, such as thromboxane and 12-HHTrE. Interestingly, collagen-induced platelet MPs dominantly produced 12(S)-HETE, consistent with the reported activation of 12-LO through the immunoreceptor-based activation motif-containing the FcRγ chain involved in collagen signaling (57) . 12(S)-HETE is a too-often neglected mediator, and its exact clinical significance remains a matter of debate (58) . It is thought to be involved in the reorganization of the actin cytoskeleton (59), hypertension (60), angiogenesis, and cancer (61) . On the other hand, BLT 2 is itself implicated in atherosclerosis (62, 63) , cancer (64) , and inflammation (65) . Thus, it is probable that MP internalization might take place in a broad range of conditions, considering that it also might occur in BLT 2 -expressing cells other than neutrophils, such as mast cells, endothelial cells, and fibroblast-like synoviocytes (42, 66, 67) .
MPs lacking 12-LO were not internalized, even in the presence of exogenous 12(S)-HETE. Furthermore, the S enantiomer, but not the R enantiomer, of 12-HETE triggered MP internalization, suggesting that MPs from cell lineages other than platelets might engage distinct mechanisms that have yet to be identified. In humans, the S enantiomer of 12-HETE is produced primarily by platelet-type 12-LO, which might be transferred from platelets to other cells so that they too produce 12(S)-HETE. Indeed, studies have identified platelet-type 12-LO in skin fibroblasts and in fibroblast-like synoviocytes from patients with psoriasis and RA (68, 69) , suggesting that MPs derived from these cells also might be capable of conveying 12-LO and of using 12(S)-HETE to promote their internalization. Because both platelet MPs and sPLA 2 -IIA are present in inflamed SF (21, 28) , one might ask whether 12(S)-HETE is found in RA SF. Of interest is that 5,12 (S)-diHETE, which is produced only through the coordinated action of leukocyte 5-lipoxygenase and platelet 12-LO, is the most abundant eicosanoid in SF of patients with RA (70), thus suggesting the potential for platelet MP internalization in neutrophils. Future studies will undoubtedly uncover the role of 5,12(S)-diHETE in inflammation.
We report an extensive set of transcription factors and nucleic acids expressed by platelet MPs, which frequently localize near the nucleus and organelles once internalized by neutrophils. Given that miRNAs are recognized as potent modulators of mRNA expression, their transfer to the recipient cell through EVs has received considerable attention (16); however, we emphasize that the MP cargo is far more extensive and contains other modulators besides miRNAs, including mRNAs, ncRNAs, transcription factors, active enzymes (such as 12-LO), cytokines, unique lipids, and even organelles such as mitochondria (11) , all of which are potentially capable of contributing to reprogramming of the recipient cell. Accordingly, MPs could regulate transcripts on internalization by neutrophils (SI Appendix, Fig. S11 A and B and Dataset S4), thereby potentially modulating the biological processes and primary functions of these recipient cells. Although these observations suggest that the internalization of MPs may alter neutrophil functions, a feature seen in RA (24), definitively identifying the actual contribution of each individual MP component to the recipient cell is premature. The present study serves to highlight the complexity of the platelet MP cargo and, most importantly, to reveal how platelet MP transfer occurs.
The EV content is highly diversified, with different cellular lineages producing EVs. Furthermore, depending on the biological context, distinct cellular recipients might require specific EV cargoes for their functions and might be specifically targeted by particular EVs. Consistent with this idea, we have demonstrated that platelet MPs are not passively internalized by recipient cells. Specific transfer of the extensive platelet MP cargo to target cells is regulated by a lipid mediator that is unique to and produced by MPs (Fig. 7) .
Materials and Methods
More details are provided in SI Appendix, SI Materials and Methods.
Patients. SF was obtained from the affected knees of six patients with RA, including four with positive rheumatoid factors (RFs) and two with no detectable RFs, with their informed consent under the approval from the Centre Hospitalier Universitaire de Québec's Ethics Committee. The patients (five females and one male, aged 20-60 y) were not treated with any medications before SF collection.
Mice. Guidelines of the Canadian Council on Animal Care were followed for all our studies in a protocol approved by the Animal Welfare Committee at Laval University. Eight-week-old male C57BL/6J (sPLA 2 four groups. The mice were killed at 3 h after MP injection. The ankles were digested for 3 h at 37°C with collagenase IV (Worthington; 1 mg/mL in white RPMI medium). Digestion products were sifted through a filter (70-μm cell strainer). Under these conditions, the number of neutrophils in digested ankles remained similar in each group of mice, and 40 ± 6% of total Hoechst + cells were GR1 + and displayed polylobed nuclei. Cells were washed twice with RPMI medium and centrifuged at 1300 × g for 5 min at room temperature (RT). Pellets were resuspended in 1X HBSS and fixed with paraformaldehyde (PFA) 2% (vol/vol) (final concentration) during 15 min at RT. Fixed cells were cytospun for 3 min at 500 rpm for confocal microscopy investigation.
Cells and Microparticles.
Platelet MPs. Human and mouse platelets were obtained from citrated blood of healthy human donors under an Institutional Review Board-approved protocol (Centre de Recherche du Centre Hospitalier Universitaire de Québec and Université Laval) (31) and healthy 12-to 15-wk-old mice, respectively. Platelets were isolated after centrifugation of blood (282 × g for 10 min at RT), after which the supernatant (platelet-rich plasma) was centrifuged at 600 × g for 5 min at RT. The supernatant was then centrifuged at 1,300 × g for 5 min at RT, and the pellet containing platelets was resuspended in Tyrode's buffer (pH 7.4) containing 5 mM calcium. Platelets were counted (Cellometer AutoM10; Nexcelom Bioscience) and adjusted to a density of 100 × 10 6 cells/mL before stimulation with collagen (0.5 μg/mL; Takeda Austria) for 18 h. When required, platelets were prelabeled with 1 μM CMFDA (green fluorescent) or CMPTX (red fluorescent) (Invitrogen) for 15 min at 37°C in the dark before stimulation. Contaminating remnant platelets were removed by centrifugation at 1300 × g for 5 min at RT, performed twice. Supernatants containing platelet MPs were centrifuged at 18,000 × g for 90 min at 18°C. Pellets containing MPs were resuspended in Tyrode's buffer (pH 7.4) with 5 mM calcium and quantified by flow cytometry using a FACSCanto II equipped with a small particle option (BD Biosciences) as described previously (31) . The chosen parameters were optimal to detect polystyrene particles from 100 to 3,500 nm simultaneously on the forward scatter channel coupled to a photomultiplier tube, and all MP preparations were confirmed to contain no trace of platelets (SI Appendix, Fig. S1B ). Human Primary Neutrophils. Polymorphonuclear neutrophils were isolated from citrated blood of healthy adult volunteers as described previously (72) . Cells (density of 5 × 10 6 cells/mL) were kept in Mg
2+
-free 1X HBSS with Ca 2+ and left unstimulated (native) or primed with TNF (100 U/mL) and GM-CSF (10 ng/mL) (Peprotech) (72) , and activated using immune complexes (heataggregated IgG, 1 mg/mL final concentration) prepared by heat aggregation of human IgG (25 mg/mL; Sigma-Aldrich) for 1 h at 63°C. Human neutrophils (2.5 × 10 5 ) were labeled with 1 μM CMPTX for 15 min at 37°C (when required) and then incubated for 2 h at 37°C with 17.5 × 10 6 fluorescent MPs (equivalent to 2 μg of proteins) or 70 MPs/neutrophil in a final volume of 50 μL. Thus, MPs (350,000 MPs/μL) were incubated with neutrophils (5 × 10 6 cells/mL) in 50 μL. When the role of sPLA 2 -IIA on internalization was assessed, the recombinant enzyme (73) or its inactive mutant was added (0.1 μg/mL final concentration) for 1 h on MPs (on ice, to permit association of the enzyme with MPs) before the addition of MPs to neutrophils. In some experiments, the BLT 1 receptor antagonist (CP105696, 10 nM; Pfizer Global Research and Development, a generous gift from Dr. Pierre Borgeat, Centre Hospitalier Universitaire de Québec), the BLT 2 receptor antagonist (LY255283, 100 nM; Cayman) and lipid mediators 12(S)-HETE (0.1-10 μM), 12(R)-HETE (0.1-10 μM), 12-HHTrE (1 μM), thromboxane B 2 (1 μM), and thromboxane A 2c (1 μM) (all from Cayman) were added to neutrophils before the addition of MP. Neutrophil-Like Cell Line. PLB-985 cells (Deutsche Sammlung von Mikroorganismen und Zellkulturen) were kept at 0.2 × 10 6 cells/mL in RPMI medium containing 10% FBS and then differentiated into neutrophil-like cells by the addition of 0.3 mM dibutyryl-cAMP (dbAMPc; Sigma-Aldrich) over 3 d. Cells, at a density of 5 × 10 6 cells/mL, were kept in Mg 2+ -free 1X HBSS with Ca 2+ , and labeled with 1 μM CMPTX for 15 min at 37°C in the dark when indicated. Neutrophil-like cells were primed and activated as described for primary neutrophils.
Confocal Microscopy.
Cell Preparation. Cells were fixed with 2% (vol/vol) PFA (final concentration) for 15 min at RT and then centrifuged using a cytospin protocol (500 rpm for 3 min at RT). For intracellular CD41 and COUP TF-I detection, cells were permeabilized with 0.5% saponine (Sigma-Aldrich) in 1X PBS twice for 5 min at RT. They were then treated with saturation solution (0.05% saponine, 5% FBS, and 5% horse serum) for 20 min at RT. Fluorescently conjugated markers were used to discriminate surface and intracellular compartments and to distinguish neutrophils and platelet MPs. Neutrophil surfaces were labeled with FITC-conjugated anti-CD66b (1 μg/mL; Beckman Coulter), cytoplasm was labeled with 1 μM CMPTX, and nuclei were labeled with either 1 μg/mL Hoechst 33342 (Invitrogen) or DRAQ5 (1/100; Cell Signaling Technology). When murine neutrophils were isolated from arthritic joints, fixed cells were labeled with Alexa Fluor 488-conjugated anti-GR1 (1.66 μg/μL; BD Bioscience) for 1 h. For experiments using CD66b
+ cells purified with magnetic beads (Stemcell Technologies) from the SF of patients with RA, PE-conjugated anti-CD41 (20 μg/mL, (clone M148; Abcam) and FITC-conjugated anti-CD66b were used to label MPs and neutrophils, respectively. The COUP-TF I expression in human cells was determined using antibody against COUP-TF I (1 μg/mL, clone H8132; R&D Systems). Image Analyses. To quantitatively assess the localization of fluorescent MPs in vitro, images were processed after cropping individual neutrophils in a XYZ mode. Each MP (green) was analyzed for localization within the neutrophil cytoplasm (red), counted, and classified in either intracellular or surface groups. MP internalization in 100 neutrophils per condition was quantified and repeated at least three times using neutrophils and MPs from different blood donors.
To quantitatively assess localization of fluorescent MPs in vivo and ex vivo (i.e., in arthritic joints), images were also processed after cropping individual neutrophils in XYZ mode. Because MPs internalized in vivo do not display punctate signals (possibly owing to membrane metabolism in the recipient), intracellular fluorescent signals were quantified slightly differently. The fluorescence corresponding to red MPs injected in mice, inside the boundary given by the GR1 membrane labeling, was quantified using velocity software as mean fluorescence intensity (MFI). The specific MP internalization was calculated after substracting the MFI of neutrophils from mice injected with control diluent (PBS).
Lipidomics. MPs (350,000 MPs/μL, or a total of 2.1 × 10 8 MPs in 600 μL, equivalent to 23 μg) were incubated in Tyrode's buffer (without BSA) at 37°C for 30 min and 6 h in the presence or absence of human recombinant sPLA 2 -IIA (0.1 μg/mL and 1 μg/mL). EGTA (20 mM) was added to stop the reaction. Then 200 μL of the reaction mixture was mixed with 800 μL of chloroform/methanol (2:1), followed by the addition of 15 μL of internal deuterated standard mixture. Lysophospholipid, fatty acid and eicosanoid analysis by combined liquid chromatography/tandem mass spectrometry was performed as described previously (74, 75) .
Statistics. The number of replicates (n) indicates the number of replicated experiments using cells from n different blood donors. Statistical analyses (t test, ANOVA, Mann-Whitney) were performed using GraphPad Prism version 5.
SI Appendix
Supplementary methods
Characterization of MPs
Stimulation of platelets
Platelets (100.10 6 platelets/ml) were stimulated with collagen (0.5µg/ml, 18h) or (in Fig. S3b) with thrombin (Sigma, 0.1U/ml 1h), or XL-CRP (generous gift from Richard W. Farndale, UK, 400ng/ml, 2h).
Density gradient
Density gradient was used to further characterize MPs taking in consideration the heterogeneity of MPs. Iodixanol (Optiprep, Sigma, stock 60%) was diluted in PBS 1X (filtered on 0.2µm) to obtain 5%, 10%, 20%, 40% of iodixanol. The discontinuous gradient was formed with a 3ml layer of the 40% solution overlaid with 3ml of the 20%, 10% and 5% solutions, successively. Concentrated MPs (100µl in Tyrode buffer corresponding to an average of 8.10 8 MPs or 87µg of protein) were put on top of the gradient. Gradients were centrifuged at 100 000g, 18h, 4°C. Each fraction (1ml) was carefully collected. Fraction 1 corresponds to the bottom of the gradient, and fraction 12 corresponds to the top of the gradient. Each fraction was divided for size analysis (10%) and EV content analysis (90%). For EV content analysis, proteins were precipitated with 15% (final concentration) of trichloroacetic acid (TCA, Sigma) during 30 min on ice. Precipitates were centrifuged at 13000g, 15 min at 4°C, then washed twice with acetone (Fisher). Pellets were resuspended in 100µl PBS1X. Twenty microliters were solubilized in Laemmli's sample buffer and analyzed by SDS-PAGE.
Size analysis
Concentrated MPs and fractions (3 to 7) of gradients were diluted at 1/1000 in PBS1X (filtered with 0.2µm) and analyzed on Zetasizer Nano S (Malvern instrument, Ltd., Malvern, UK).
MP localization
To visualize organelles, neutrophils were pre-labeled with 1µM of ER-tracker TM (Invitrogen), Golgi-ID TM (1X, Enzo Life Science), 100nM MitoTracker® Deep (Invitrogen) and 100nM of LysoTracker® Red(Invitrogen) during 30min 37°C, prior to incubation with compatible fluorescently labeled MPs.
Genotyping
PCR was used to confirm the genotype of sPLA 2 -IIA TGN ALOX12 -/-mice. Tail tips were collected and processed with direct PCR lysis Reagent (Viagen biotech inc) and proteinase K (1/50 Wisent). Primers (Integrated DNA techonologies IDT) used for specific amplification of ALOX12 were (5' CCT CAG TGC AGG AAC CTG TG 3'), (5' CTG CTA CCC ATG GCT ATC CAG 3') and (5' TAC TTC CAT TTG TCA CGT CCT G 3'). The PCR cycling condition consisted of an initial step at 95°C for 15min, followed by a three-step amplification at 94°C for 45s and 58°C for 60s and 72°C for 60s (35 cycles) then 72°C for 10min on PTC-200 (Peltier Thermal Cycler, MJ research). The denatured samples were centrifuged (600g, 20min at 4°C) and the supernatants were then evaporated to 1ml using a stream of nitrogen (in a water bath at 22°C) and analyzed by HPLC as described previously (2) . Quantification of the various metabolites was achieved by using the internal standards. For calibration, 12-HETE and 12-HHTrE were used.
Reagents for confocal microscopy Cells were mounted with Prolong gold anti-fade reagent (Invitrogen). Cells were analyzed by spinning disc confocal microscope using 63x objective (Quorum Spinning Disc Wave FX, Quorum technologies, Guelph, Canada) and Velocity software version 5.4.0. For 3D imaging, cells were analyzed using an IX81-ZDC confocal microscope equipped with a FV1000 scanning head and an Olympus 60X OSC NA 1.4 objective lens. Acquisition and exportation of z-stacks were performed with Fluoview imaging software ASW3.1a (Olympus America Inc). Maximum intensity projections and volume rendering were calculated using Surpass module in Bitplane Imaris 7.5.1.
Electronic microscopy
For scanning electronic microscopy, samples were fixed with 2.5% glutaraldehyde and 2% PFA for at least 24h, then the samples were fixed with osmium tetroxide (1% in sodium cacodylate buffer), dehydrated, air-dried and finally metalized with gold palladium. Cells were observed with a JEOL 6360LV scanning electron microscope (Tokyo, Japan). For transmission electronic microscopy, samples were fixed in PFA 2% 24h before deshydrated, embedded in LR white. Samples were stained with uranyl acetate 3%, 5minutes and analyzed on a FEI Tecnai G2 Spirit BioTWIN transmission electron microscope at 80kV.
Immunoblotting analyses
Platelet and MPs were lysed in lysis buffer (20mM Tris HCl pH7.8, 1.25mM EDTA, 0.5% triton, 0.5% NP-40, 120mM NaCl, 2mM PMSF, Sigma). Protein content of lysates was determined using the Pierce BCA protein assay kit (Fisher). Proteins (10µg or 91.10 6 MP ± 20.10 6 ) were separated in SDS-PAGE (10%), transferred to a PVDF membrane and the candidate proteins were detected using antibodies against 12-LO (Santa Cruz, used at 1µg/ml), Txs (Cayman, used at 1µg/ml), Cox-1 (Cayman, used at 5µg/ml), β-actin (Sigma, clone AC-15 used at 1/15000) both forms of COUP-TF (COUP-TF I/NR2F1 and COUP-TF II/ NR2F2) (R&D Systems, used at 1µg/µl), NFκB (Cell signaling, used at 1/1000), TSG101 (abcam, clone 4A10 used at 0.1mg/ml) and VDAC (Cell signaling used at 11.6µg/ml). The membranes were incubated with peroxidaseconjugated antibodies recognizing primary antibodies (Jackson Immunoresearch, used at 0.08µg/ml).
Detection of transcription factors
Lysates of platelets and MPs (15µg equivalent to 1.36.10 8 MP ± 30.10 6 ) were analyzed using TF Activation Profiling Plate arrays II (Signosis) according to manufacturers protocol and quantification was determined using relative luminescence unit (RLU) for each condition.
DNA precipitation assay COUP TF-I binding assay was performed as described elsewhere (3) . Briefly, streptavidin magnetic beads (30µl, Promega) were washed twice with 1X B&W buffer (5 mM Tris pH 7.5, 0.5 mM EDTA, 1 M NaCl) then 100 ng of a biotinylated binding sequence of COUP-TF I (5'Biotin TGC TCT TGC TAG GTC ATA GGT CAT CTT GCT 3') and (5' AGC AAG ATG ACC TAT GAC CTA GCA AGA GCA 3') (IDT) were bound to the beads in 1X B&W buffer for 1 h at RT. Beads were washed twice in 1X B&W buffer, once with 1X binding buffer (5% glycerol, 20 mM Tris pH 7.5, 1 mM EDTA, 1 mM DTT, 0.15% Triton X-100, 100 mM NaCl, 4 mM MgCl2) and blocked with 1% BSA for 1 h at 4°C. Bound biotinylated oligonucleotides were then mixed with 10 µg of poly (dI-dC) and 50µg of MP lysates (equivalent to 4. were labeled using flashTag Biotin HSR (Genisphere, Hatfield, PA) and hybridized on Gene Chip 2.0 ST (Affymetrix, Santa Clara, CA) and Gene Chip miRNA 3.0 Array, respectively. Arrays were scanned on a GeneChip scanner 3000 G7 (Affymetrix), and CEL files were analyzed with the Partek software version 6.6 (Partek Incorporated). Microarrays from total RNA were subjected to background substraction by using robust multi-array analysis (RMA) and logarithmic transformation. A threshold was applied to normalized data and excluded mRNAs and miRNAs with intensity values lower than the median of data set expression matrix, which is 5 and 1.3 for RNAs and miRNAs respectively. RNA profiles of neutrophils incubated with sPLA 2 -IIA versus neutrophils incubated with a combination of MPs and sPLA 2 -IIA were compared by ANOVA in Partek software. RNA changes between neutrophils and neutrophils incubated with a combination of MPs and sPLA 2 -IIA were selected based on this criterion: 1.5 fold change in expression in either direction was required.
Quantitative RT PCR
Quantitative PCR was used to confirm the RNA modulations identified in Arrays. RNA from 15x10 6 neutrophils in indicated conditions was isolated using Trizol (Invitrogen) and following the procedure of the manufacturer. RNA (1µg) was subjected to reverse transcription using MLV-RT (Invitrogen). Primers and probes (IDT) were used for specific amplification of CCL5 (5' TGC CCA CAT CAA GGA GTA TT 3', forward; 5' GTA CTC CCG AAC CCA TTT CT 3', reverse), PPBP (5' TGA TAC CAC CCC TTC CTG TA 3', forward; 5' GCG GAG TTC AGC ATA CAA GT 3', reverse), NCF-1 (5' ACA CCT TCA TCC GTC ACA TC 3', forward; 5' TAG ACC ACC TTC TCC GAC AG 3', reverse), GAPDH (5' CAA CGG ATT TGG TCG TAT TGG 3', forward; 5' GCA ACA ATA TCC ACT TTA CCA GAG TTA A 3' reverse). The qPCR cycling condition consisted of an initial step at 50°C for 2min, 95°C for 10min followed by a three-step amplification at 95°C for 15s and 56°C or 58°C for 30s and 72°C for 30s (40 cycles) on Rotor Gene-3000 (QIAgen). Relative expression of interest gene was performed by using the following formula: 2 -∆Ct , ∆Ct corresponds to Ct mean (interest gene) -Ct mean (GAPDH).
MicroRNA functional assays
The miR-451 reporter constructs were created by inserting a sequence complementary to hsamiR-451 in the Xho1/Not1 sites of psiCHECK-2 vector (Promega), downstream of the Renilla luciferase reporter gene. All the constructs were verified by DNA sequencing. db-AMPc differentiated PLB-985 were transfected by nucleofector system from Amaxa (2x10 6 (Left panels) Representative confocal microscopy images of neutrophil endoplasmic reticulum (ER) (a), Golgi apparatus (Golgi) (b), lysosome (Lyso) (c), mitochondria (Mito) (d) visualized using false color (red) and green platelet MPs. The neutrophil plasma membrane was identified using anti-CD66b (cyan) (for ER, Golgi and lysosome labeling). Cytoplasm is shown in cyan (for mitochondria labeling). Nuclei of neutrophils were labeled in blue. Co-localizations are indicated with white arrows (n=3). Scale bars represent 10µm. (Right panels) Graph bars show the percentage of neutrophils in which MPs localize with specific organelles and the percentage of organelles that co-localize with intracellular MPs. Data were obtained by confocal microscopy on 100 neutrophils per condition (n=3). Graph bars indicate the relative localization (surface vs intracellular) of the MPs, depending on the neutrophil treatment. Activated neutrophils were treated with dynasore (dynamin inhibitor, dyn, 50µM), nocodazole (microtubule polymerization inhibitor, noco, 10µM), chlorpromazine (clathrine dependant endocytosis inhibitor, chlo, 40µM) and nystatin (clathrine independant endocytosis inhibitor, nys, 1µg/ml) before MP incubation. MPs were pre-incubated with/out sPLA 2 -IIA. Data were obtained from 100 neutrophils per condition repeated at least 3 times with cells from different donors (n=3, MannWhitney test compared to diluent *** p<0.0001). (a) LPC (10µM) was exogenously added to activated neutrophils in presence of MPs and the internalization was determined using confocal microscopy. Data were obtained from 100 neutrophils per condition (n=3, Mann Whitney test, compared to diluent, *** p<0.0001). (b) MPs were treated with cyclooxygenase inhibitor indomethacin (20µM, 10min, 22°C) and added to activated neutrophils 2h at 37°C. The quantification of internalization was assessed using confocal microscopy on 100 neutrophils per condition (n=3, Mann Whitney test comparing to diluent, *** p<0.0001). Cell blood analysis from indicated mice were determined using an automatic cell counter (Biovet Inc, Québec, Canada) (n=5 mice per groups, Mann-Whitney test **p<0.05 ***p<0.01). 
